Danielle Kamato

14PUBLICATIONS
23CO-AUTHORS
Major global burdens of diseaseGene and molecular therapyCardiology (incl. cardiovascular diseases)Epidemiological modellingInfectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 26, 2025
The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21.

Suowen Xu, Zhenghong Liu, Tian Tian

|Nov 26, 2022
Gαq Is the Specific Mediator of PAR-1 Transactivation of Kinase Receptors in Vascular Smooth Muscle Cells.

Danielle Kamato, Mai Gabr, Hirushi Kumarapperuma

|Nov 11, 2022
Non-Mouse Models of Atherosclerosis: Approaches to Exploring the Translational Potential of New Therapies.

Danielle Kamato, Iqra Ilyas, Suowen Xu

|May 09, 2022
Endothelin-1 dependent expression of GAG genes involves NOX and p38 mediated Smad linker region phosphorylation.

Hossein Babaahmadi-Rezaei, Raafat Mohamed, Parisa Dayati

|Feb 05, 2022
Lipopolysaccharide acting via toll-like receptor 4 transactivates the TGF-β receptor in vascular smooth muscle cells.

Rizwana Afroz, Hirushi Kumarapperuma, Quang V N Nguyen

|Jan 04, 2022
Endothelin-1 mediated glycosaminoglycan synthesizing gene expression involves NOX-dependent transactivation of the transforming growth factor-β receptor.

Hossein Babaahmadi-Rezaei, Peter J Little, Raafat Mohamed

Pageof 3